Rick Schreurs

56 Chapter 3 REFERENCES 1 Nikolaidou T, Ghosh JM, Clark A. Outcomes Related to First-Degree Atrioventricular Block and Therapeutic Implications in Patients With Heart Failure. JACC Clin Electrophysiol. 2016;2(2):181–92. 2 Gervais R, Leclercq C, Shankar A, Jacobs S, Eiskjær H, Johannessen A, et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail. 2009;11(7):699–705. 3 Olshansky B, Day JD, Sullivan RM, Yong P, Galle E, Steinberg JS. Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: An analysis from the COMPANION Trial. Hear Rhythm. 2012;9(1):34–9. 4 Park S-J, On YK, Byeon K, Kim JS, Choi J-O, Choi D-J, et al. Short- and long-term outcomes depending on electrical dyssynchrony markers in patients presenting with acute heart failure. Am Heart J. 2013;165(1):57-64.e2. 5 Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, et al. Long-termOutcomes in Individuals with a Prolonged PR Interval or First-Degree Atrioventricular Block. JAMA. 2009;301(24):2571–7. 6 Ishikawa T, Kimura K, Miyazaki N, Tochikubo O, Usui T, Kashiwagi M, et al. Diastolic mitral regurgitation in patients with first-degree atrioventricular block. Pacing Clin Electrophysiol. 1992;15(11 Pt 2):1927–31. 7 Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet. 1992/11/28. 1992;340(8831):1308–12. 8 Hochleitner M, Hörtnagl H, Hörtnagl H, Fridrich L, Gschnitzer F. Long-term efficacy of physiologic dual-chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;70(15):1320–5. 9 Sack S, Franz R, Dagres N, Oldenburg O, Herrmann J, Golles A, et al. Can right-sided atrioventricular sequential pacing provide benefit for selected patients with severe congestive heart failure? Am J Cardiol. 1999;83(5):124–9. 10 Salden FCWM, Kutyifa V, Stockburger M, Prinzen FW, Vernooy K. Atrioventricular dromotropathy: evidence for a distinctive entity in heart failure with prolonged PR interval? EP Eur. 2017;20(7):1067–77. 11 Kutyifa V, Stockburger M, Daubert JP, Holmqvist F, Olshansky B, Schuger C, et al. PR Interval Identifies Clinical Response in Patients With Non-Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Substudy. Circ Arrhythmia Electrophysiol. 2014;7(4):645–51. 12 Lin J, Buhr KA, Kipp R. Effect of PR Interval on Outcomes Following Cardiac Resynchronization Therapy: A Secondary Analysis of the COMPANION Trial. J Cardiovasc Electrophysiol. 2017;28(2):185–91. 13 Joshi NP, Stopper MM, Li J, Beshai JF, Pavri BB. Impact of baseline PR interval on cardiac resynchronization therapy outcomes in patients with narrow QRS complexes: an analysis of the ReThinQ Trial. J Interv Card Electrophysiol. 2015;43(2):145–9. 14 Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association . Eur Eur Pacing, Arrhythmias, Card Electrophysiol. 2013/06/27. 2013;15(8):1070–118. 15 Walmsley J, Squara P, Wolfhard U, Cornelussen R, Lumens J. Impact of abrupt versus gradual correction of mitral and tricuspid regurgitation: a modelling study. EuroIntervention. 2019;15(10):902–11.